Protalix BioTherapeutics, Inc. (PLX)

NYSEAMERICAN: PLX · Real-Time Price · USD

2.890

+0.050 (1.76%)

At close: May 8, 2025, 4:00 PM

2.230

-0.660 (-22.84%)

Pre-market: May 9, 2025, 9:15 AM EDT

Protalix BioTherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	53.4	65.49	47.64	38.35	62.9	Upgrade
Revenue Growth (YoY)	-18.47%	37.48%	24.22%	-39.03%	15.00%	Upgrade
Cost of Revenue	24.32	22.98	19.59	16.35	10.87	Upgrade
Gross Profit	29.08	42.51	28.05	22	52.03	Upgrade
Selling, General & Admin	12.19	14.96	11.71	12.73	11.15	Upgrade
Research & Development	12.97	17.09	29.35	29.73	38.17	Upgrade
Operating Expenses	25.16	32.05	41.06	42.46	49.32	Upgrade
Operating Income	3.92	10.46	-13.01	-20.46	2.71	Upgrade
Interest Expense	-1.06	-3.18	-2.53	-7.52	-9.67	Upgrade
Interest & Investment Income	1.3	1.29	1.15	0.4	0.44	Upgrade
EBT Excluding Unusual Items	4.15	8.57	-14.4	-27.58	-6.52	Upgrade
Pretax Income	4.15	8.57	-14.4	-27.58	-6.52	Upgrade
Income Tax Expense	1.22	0.25	0.53	-	-	Upgrade
Earnings From Continuing Operations	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income to Common	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income Growth	-64.73%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	73	68	48	44	29	Upgrade
Shares Outstanding (Diluted)	81	82	48	44	29	Upgrade
Shares Change (YoY)	-1.66%	70.04%	9.81%	51.43%	96.44%	Upgrade
EPS (Basic)	0.04	0.12	-0.31	-0.62	-0.22	Upgrade
EPS (Diluted)	0.04	0.09	-0.31	-0.62	-0.22	Upgrade
EPS Growth	-57.71%	-	-	-	-	Upgrade
Free Cash Flow	7.39	-2.47	-25.63	-11.74	-26.76	Upgrade
Free Cash Flow Per Share	0.09	-0.03	-0.53	-0.27	-0.92	Upgrade
Gross Margin	54.46%	64.91%	58.87%	57.37%	82.71%	Upgrade
Operating Margin	7.33%	15.97%	-27.32%	-53.36%	4.31%	Upgrade
Profit Margin	5.49%	12.69%	-31.33%	-71.92%	-10.37%	Upgrade
Free Cash Flow Margin	13.84%	-3.77%	-53.80%	-30.62%	-42.55%	Upgrade
EBITDA	5.22	11.65	-11.93	-19.34	4.01	Upgrade
EBITDA Margin	9.78%	17.79%	-25.04%	-50.44%	6.38%	Upgrade
D&A For EBITDA	1.3	1.19	1.09	1.12	1.3	Upgrade
EBIT	3.92	10.46	-13.01	-20.46	2.71	Upgrade
EBIT Margin	7.33%	15.97%	-27.32%	-53.36%	4.31%	Upgrade
Effective Tax Rate	29.42%	2.96%	-	-	-	Upgrade
Revenue as Reported	53.4	65.49	47.64	38.35	62.9	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q